Stockscreener 앱 받기
27.60
0.82%
-0.32
Moderna Inc 주식(MRNA)의 최신 뉴스
Is Moderna Inc. trending in predictive chart modelsRate Hike & Daily Stock Trend Reports - newser.com
Moderna, Inc. $MRNA Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
GSK Doesn't Have To Explain COVID Vax Claims For Moderna - Law360
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing - sharewise.com
Updated COVID shot led to less severe illness, fewer hospitalizations last year, US study finds - MarketScreener
Moderna, Inc. (MRNA) Stock Update – Oct 8 2025: Will the mRNA Trailblazer Bounce Back or Sink Further? - ts2.tech
Moderna, Inc. (MRNA): Among the Best Vaccine Stocks to Buy According to Hedge Funds - MSN
Moderna (MRNA) COVID-19 Booster Recommendations Updated by CDC - GuruFocus
CDC adopts individual-based decision-making for COVID-19 shots (MRNA:NASDAQ) - Seeking Alpha
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Fut - GuruFocus
Moderna - WCIV
Moderna (MRNA): Assessing Valuation After Recent 12% Share Price Jump and Updated Financials - Yahoo Finance
Will Moderna Inc. see short term momentum2025 Year in Review & Fast Moving Stock Trade Plans - newser.com
Key metrics from Moderna Inc.’s quarterly data2025 EndofYear Setup & Step-by-Step Swing Trade Plans - newser.com
Day 5 of Gains Streak for Moderna Stock with 16% Return (vs. -31% YTD) [10/3/2025] - Trefis
Moderna Inc. (MRNA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans - Greenville Online
Moderna Says GSK ‘Abusing’ Patents to Siphon Covid Shot Profits - Bloomberg Law News
How to interpret RSI for Moderna Inc. stockMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
What high frequency data says about Moderna Inc.Market Trend Review & Daily Stock Momentum Reports - newser.com
Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
The CDC still hasn't issued COVID vaccine guidelines, leaving access in limbo - NPR
What to know about this fall’s COVID-19 vaccine - The Globe and Mail
November 14th Options Now Available For Moderna (MRNA) - Nasdaq
6 Healthcare Stocks Positioned to Soar After Trump-Pfizer Deal - Investing.com
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? - The Globe and Mail
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance
Union Bancaire Privee UBP SA Sells 15,518 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Public Employees Retirement System of Ohio - MarketBeat
Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results - Yahoo
Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - MarketBeat
Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK - Detroit Free Press
Moderna Stock Is Rallying Wednesday: What's Driving The Action? - Benzinga
Moderna (NASDAQ:MRNA) Shares Up 5.9%Here's Why - MarketBeat
Is Moderna Inc (MRNA) Set to Underperform? Analyzing the Factors Limiting Growth - GuruFocus
Moderna (MRNA) Continues Upward Trend in Early Trading - GuruFocus
mRNA Vaccine and Therapeutics Market to Hit USD 127.8 Billion by 2034, Growing at 10.7% CAGR - openPR.com
Applying chart zones and confluence areas to Moderna Inc.Market Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
Tools to assess Moderna Inc.’s risk profileGDP Growth & Pattern Based Trade Signal System - newser.com
Automated trading signals detected on Moderna Inc.IPO Watch & Weekly Watchlist for Hot Stocks - newser.com
UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Online Athens
mRNA Market Forecasted to Reach USD 128.6 Billion by 2034, Key Players: Moderna & Pfizer/BioNTech - openPR.com
2 Beaten-Down Stocks to Buy and Hold for a Decade - Yahoo Finance
Chart based exit strategy for Moderna Inc.2025 Market WrapUp & Daily Price Action Insights - newser.com
Moderna, Inc. (MRNA) Stock Analysis: Navigating the 80.69% Potential Upside Amidst Challenges - DirectorsTalk Interviews
Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 - The Daily Jeffersonian
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 - The Daily Jeffersonian
0.81%
1.16%
자본화:
|
볼륨(24시간):